Renaissance Technologies - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 109 filers reported holding IMMUNOCORE HLDGS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$23,682
-11.7%
456,300
+2.0%
0.04%
+2.6%
Q2 2023$26,820
+22.0%
447,300
+0.6%
0.04%
+34.5%
Q1 2023$21,981
+26.2%
444,600
+45.7%
0.03%
+20.8%
Q4 2022$17,412
-99.6%
305,100
+221.8%
0.02%
+300.0%
Q3 2022$4,450,000
+134.3%
94,800
+86.2%
0.01%
+200.0%
Q2 2022$1,899,000
+771.1%
50,900
+597.3%
0.00%
Q1 2022$218,0007,3000.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$29,942,30435.70%
RTW INVESTMENTS, LP 6,096,387$316,402,4856.68%
Paradigm Biocapital Advisors LP 1,384,686$71,865,2034.88%
Rock Springs Capital Management LP 2,943,710$152,778,5494.09%
Logos Global Management LP 450,000$23,355,0003.12%
TANG CAPITAL MANAGEMENT LLC 405,600$21,050,6402.97%
GREAT POINT PARTNERS LLC 290,917$15,098,5922.75%
Nicholas Investment Partners, LP 512,855$26,617,1751.99%
Eschler Asset Management LLP 30,000$1,557,0001.82%
COWEN AND COMPANY, LLC 460,036$23,875,8681.67%
View complete list of IMMUNOCORE HLDGS PLC shareholders